I received an e-mail this week from Genentech BioOncology, introducing their new Co-Pay Card Program. Genentech is the maker of the two drugs I have blogged about involved in the current macular degeneration treatment controversy, Lucentis and Acastin. According to the e-mail: “We are committed to ensuring that all eligible patients have access to the…
Here is another reason to watch the fat intake. We have known for years that a low fat diet can aid in weight reduction. A new study reported in this month’s Archives of Ophthalmology, Association Between Dietary Fat Intake and Age-Related Macular Degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS)An Ancillary Study of…
There is an interesting article in this month’s Lancet: Age-dependent effects of RPE65 gene therapy for Leber’s congenital amaurosis: a phase 1 dose-escalation trial. Results were also reported in yesterday’s New York Times. According to the Lancet article: Gene therapy has the potential to reverse disease or prevent further deterioration of vision in patients with…
Our world-class team of professionals at OCLI can help you with the latest treatment options for you.
Schedule an appointment
Are you a new patient? *
Start your search. Search by location or provider.
Please choose your preferred provider: *
Please complete the following to request your appointment:
Note: Self-scheduling is currently available for select locations. More locations will be available soon.
Loading...
Please complete the following to request your appointment:
Note: Self-scheduling is currently available for select locations. More locations will be available soon.
Loading...
Please complete the following to request your appointment:
Note: Self-scheduling is currently available for select locations. More locations will be available soon.
Loading...
Self-scheduling is not currently available for this provider, please complete form below and a member of the OCLI Vision team will contact you to schedule your appointment.
The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania and West Virginia and specialize in primary vision care, LASIK, cataract surgery, glaucoma, diabetic eye care, and other services for patients in the Northeast.
These locations include practice locations of OCLI Vision as well as the practice locations of other vision services providers and ambulatory surgery centers supported by the administrative services of Spectrum Vision Partners. Each location is identified by the vision service provider or company operating at the location.